We asked eight up-and-coming and top mutual fund managers what one stock they would buy now. Some of their recommendations are household names. Others might surprise you.
Use the navigation at the right to scroll through our slide show to see if you would like to add these managers' picks to your portfolio.
By Elizabeth Ody, Andrew Tanzer and Jeff Kosnett
Compiled by Cameron Huddleston
THE ONE STOCK THEY WOULD BUY
MANAGER: Bob Auer, Auer Growth Fund (AUERX (opens in new tab))
STOCK: Noble Corp. (symbol NE (opens in new tab))
Bob Auer recently launched Auer Growth with his father, Bryan. The pair already have a remarkable record managing Bryan's retirement account, which returned an astonishing 30% annualized over the past 20 years through the end of the third quarter of 2007.
Auer says of Noble: This is an offshore driller that operates deep-water rigs for $600,000 a day. If oil dropped to $20 a barrel, it wouldn't hurt Noble because it has contracts with some of the richest companies in the world -- such as Chevron, Exxon and Petrobras -- that have locked in record earnings for the next five years.
Sponsored Content
(opens in new tab)
THE ONE STOCK THEY WOULD BUY
MANAGER: Susan Byrne, WHG LargeCap Value Fund (WHGLX (opens in new tab))
STOCK: Nike (NKE (opens in new tab))
This experienced value-oriented investor looks for stocks others misundertand. WHG LargeCap Value is a relatively new fund, but Byrne has a proven track record with Westwood Equity fund.
Byrne says of Nike: Nike has shown consistent revenue growth over the last several years and has leveraged growth from China and Latin America to consistently improve its margins. Nike products will be displayed prominently at the upcoming Olympics. And the company's entree into soccer, through the recent acquisition of Umbro, is another avenue of growth that has worldwide implications.
Sponsored Content
(opens in new tab)
THE ONE STOCK THEY WOULD BUY
MANAGER: Neil Hennessy, Hennessy Focus 30 (HFTFX (opens in new tab))
STOCK: Exxon Mobil (XOM (opens in new tab))
This well-known manager runs his own shop, Hennessy Funds, using a quantitative screening process that recently has put his Hennessy Focus 30 fund at the top of the charts now.
Hennessy says of Exxon Mobil: This is just a very well managed company that's in the right place at the right time. I'm not saying that the price of oil will necessarily go up, but Exxon will survive. It has plenty of room to raise its dividend and the capital to expand if the government opens up offshore drilling.
Sponsored Content
(opens in new tab)
THE ONE STOCK THEY WOULD BUY
MANAGER: Tom Laming, AFBA Science & Technology Fund (AFATX (opens in new tab))
STOCK: Cisco (CSCO (opens in new tab))
This former spacecraft engineer's fund has beaten its peers over the past five years.
Laming says of Cisco: It is so well-positioned after purchasing Scientific Atlanta. Cisco's benefitting from a long-term trend that's already well under way, and that's the constant and prevalent spread of semiconductor technology.
Sponsored Content
(opens in new tab)
THE ONE STOCK THEY WOULD BUY
MANAGER: Jim Moffett, UMB Scout International Fund (UMBWX (opens in new tab))
STOCK: Canon (CAJ (opens in new tab))
Moffett has 35 years of investment-management experience. Since 1993, he has managed Scout, which is in the top 10% of overseas funds that focus on large companies with a blend of growth and value attributes.
Moffett says of Canon: We view Canon as a broad-based Japanese technology play because, if you look at the numbers, Japan has been one of the best markets this year. Also, Canon’s products are diverse. We usually only think of them as making cameras, but they also make copiers and equipment for semi-conductors.
Sponsored Content
(opens in new tab)
THE ONE STOCK THEY WOULD BUY
MANAGER:John Osterweis, Osterweis Fund (OSTFX (opens in new tab))
STOCK: Valeant Pharmaceuticals (VRX (opens in new tab))
Osterweis's fund has delivered 11% annualized over the past ten years, beating the Standard and Poor's 500-stock index by an average of eight percentage points per year.
Osterweis says of Valeant: Valeant Pharmaceuticals is a global pharmaceutical company that specializes in products for neurology, infectious disease and dermatology. New management is focusing the company’s activities in fewer drugs and fewer geographies, which should enhance the company’s returns. Valeant also recently completed two successful trials of its leading drug prospect, Retigabine, and plans to file its new drug application with the Federal Drug Administration this year. This drug could help turn the somewhat sluggish firm into a growth company.
Sponsored Content
(opens in new tab)
THE ONE STOCK THEY WOULD BUY
MANAGER: Suzanne Stepan, Utopia Growth Fund (UTGRX (opens in new tab))
STOCK: Nalco Holding Co. (NLC (opens in new tab))
Stepan has been managing Utopia Growth since it was launched in 2005, but she has more than 16 years of investment management experience.
Stepan says of Nalco: Nalco is the world's largest water-treatment company. It has a new chief executive who has been implementing restructuring initiatives that should result in margin expansion over time. Plus, there is a long-term tailwind in the global water treatment market. Water is the world's blue gold and is becoming more at risk.
Sponsored Content
(opens in new tab)
THE ONE STOCK THEY WOULD BUY
MANAGER: Robert Stimpson, Black Oak Emerging Technology Fund (BOGSX (opens in new tab))
STOCK: Cognizant Technology Solutions (CTSH (opens in new tab))
Stimpson has more than 11 years of investment experience and manages two other funds for Oak Associates Funds.
Stimpson says of Cognizant: Cognizant supplies IT services to Fortune 500 companies around the world. It's particularly successful during a recession because big companies, especially financial firms, tighten their purse strings. The stock has fallen in large part due to guilt by association with trouble in the financial services industry.
Sponsored Content
(opens in new tab)
-
-
How to Get Your Long-Term Care Planning on the Right Track
Many of us are not as prepared as we should be, but it’s not too late. Taking these steps today can get you started on planning for your long-term care.
-
Stock Market Today: Tech, Bank Stocks Lead Markets Higher
Retailers were big gainers, too, thanks to strong earnings from Lululemon Athletica.
-
5 Stocks to Sell or Avoid Now
stocks to sell In a difficult market like this, weak positions can get even weaker. Wall Street analysts believe these five stocks should be near the front of your sell list.
-
Best AI Stocks to Buy: Smart Artificial Intelligence Investments
tech stocks AI stocks have been bloodied up in recent months, but the technology's relentlessly growing importance should see the sun shine on them again.
-
9 Best Stocks for Rising Interest Rates
stocks The Federal Reserve has been aggressive in its rate hiking, and it's likely not done yet. Here are nine of the best stocks for rising interest rates.
-
The 6 Safest Vanguard Funds to Own in a Bear Market
recession Batten the hatches for continued market tumult without eating high fees with these six Vanguard ETFs and mutual funds.
-
9 Best Commodity ETFs to Buy Now
ETFs These commodity ETFs offer investors exposure to the diverse asset class, which is a helpful hedge against inflation.
-
The 5 Best Inflation-Proof Stocks
stocks Higher prices have been a major headache for investors, but these best inflation-proof stocks could help ease the impact.
-
7 Best Small-Cap Stocks to Buy for 2023 and Beyond
small cap stocks Analysts say a tough 2022 has left these small-cap stocks priced for outperformance in the new year and beyond.
-
Can Stocks Picked by Artificial Intelligence Beat the Market? 3 Stocks to Watch
stocks An artificial intelligence stock-picking platform identifying high-potential equities has been sharp in the past. Here are three of its top stocks to watch over the next few months.
